These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3292735)

  • 1. Relationships between oestrogen receptor,epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer.
    Horne GM; Angus B; Wright C; Needham G; Nicholson S; Harris AL; Innes B; Horne CH
    J Pathol; 1988 Jun; 155(2):143-50. PubMed ID: 3292735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen receptor and epidermal growth factor receptor expression in male breast carcinoma.
    Fox SB; Rogers S; Day CA; Underwood JC
    J Pathol; 1992 Jan; 166(1):13-8. PubMed ID: 1538271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in breast cancer: immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status.
    Wright C; Angus B; Napier J; Wetherall M; Udagawa Y; Sainsbury JR; Johnston S; Carpenter F; Horne CH
    J Pathol; 1987 Dec; 153(4):325-31. PubMed ID: 2828590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of epidermal growth factor receptor (EGFR) in breast cancer as related to clinical, prognostic and cytometric factors.
    Pirinen R; Lipponen P; Syrjänen K
    Anticancer Res; 1995; 15(6B):2835-40. PubMed ID: 8669874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of epidermal growth factor receptor in human breast carcinoma and its correlation with morphological and biological features of tumour aggressiveness.
    Betta PG; Robutti F; Spinoglio G; Bottero G
    Pathologica; 1989; 81(1074):425-31. PubMed ID: 2626279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of breast relates to high histological grade and loss of oestrogen receptor protein.
    Looi LM; Cheah PL
    Malays J Pathol; 1998 Jun; 20(1):19-23. PubMed ID: 10879259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
    Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
    J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies for the immunohistochemical detection of estrogen receptor status in tissue sections of primary breast cancers].
    Beck T; Pollow K; Heubner A
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):490-4. PubMed ID: 3530871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E; Paszko Z; Mazur S
    Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of membrane-bound tissue type and urokinase type plasminogen activators in human breast cancers to estrogen and epidermal growth factor receptors.
    Needham GK; Nicholson S; Angus B; Farndon JR; Harris AL
    Cancer Res; 1988 Nov; 48(22):6603-7. PubMed ID: 3141047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the EGF-receptor with cell kinetic and classical prognostic factors in breast cancer.
    Oehler MK; Rehn M; Kristen P; Sütterlin M; Caffier H
    Anticancer Res; 1997; 17(4B):3137-40. PubMed ID: 9329620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
    Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
    Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of c-fos protein in human breast.
    Walker RA; Cowl J
    J Pathol; 1991 Apr; 163(4):323-7. PubMed ID: 1903442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11.
    Angus B; Napier J; Purvis J; Ellis IO; Hawkins RA; Carpenter F; Horne CH
    J Pathol; 1986 Aug; 149(4):301-6. PubMed ID: 3020217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
    Cheang MC; Treaba DO; Speers CH; Olivotto IA; Bajdik CD; Chia SK; Goldstein LC; Gelmon KA; Huntsman D; Gilks CB; Nielsen TO; Gown AM
    J Clin Oncol; 2006 Dec; 24(36):5637-44. PubMed ID: 17116944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer.
    Tsutsui S; Kataoka A; Ohno S; Murakami S; Kinoshita J; Hachitanda Y
    Clin Cancer Res; 2002 Nov; 8(11):3454-60. PubMed ID: 12429634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.